Medifast, Inc.

NYSE:MED

Personal Products & Services

Consumer Cyclical
$12.20 -0.04%

-$0.01 today

Market cap
$136.43M
Beta
0.66
P/E (TTM)
-6.2
EPS (TTM)
-$1.82
52W Low $9.22High $15.46

Volume 0.09M

Average 0.21M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

$6.86M

FY 2025 · Annual

-72.0% YoY

Investing Cash Flow

-$7.93M

FY 2025 · Annual

Financing Cash Flow

-$564,000.00

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income164.03M143.57M99.42M2.09M(18.67M)
Depreciation & Amortization6.81M10.98M13.11M17.4M14.24M
Deferred Income Tax(3.72M)(924K)1.21M(7.4M)11.46M
Stock-Based Compensation9.9M11.05M8.19M7.36M7.64M
Change in Working Capital(87.65M)21.65M20.28M(9.75M)(9.81M)
Accounts Receivables00000
Inventory(126.65M)61.19M64.27M12.17M22.19M
Accounts Payables54.38M(37.59M)(35.71M)(34.99M)(23.91M)
Other Working Capital39.01M(1.94M)(8.28M)13.08M(8.09M)
Other Non-Cash Items5.16M8.24M5.46M14.77M2M
Operating Cash Flow94.55M194.57M147.66M24.48M6.86M
Capital Expenditures(34.21M)(16.68M)(6.48M)(7.45M)(5.61M)
Acquisitions (Net)00000
Purchases of Investments00(54.56M)(46.6M)(84.41M)
Sales of Investments5.15M5.27M027.43M78.78M
Other Investing Activities00095K3.31M
Investing Cash Flow(29.06M)(11.41M)(61.05M)(26.52M)(7.93M)
Debt Repayment00000
Common Stock Issued00000
Common Stock Repurchased(62.09M)(127.96M)(6.96M)(836K)(369K)
Dividends Paid(63.86M)(71.62M)(73.02M)(715K)(195K)
Other Financing Activities811K0188K36K0
Financing Cash Flow(125.13M)(199.58M)(79.79M)(1.52M)(564K)
Effect of Forex Changes112K(67K)(72K)47K4K
Net Change in Cash(59.54M)(16.49M)6.75M(3.51M)(1.63M)
Free Cash Flow60.34M177.89M141.17M17.02M1.25M

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$18.7M
+ D&A$14.2M
+ Stock-Based Comp$7.6M
+ Deferred Tax$11.5M
- Working Capital-$9.8M
+ Other Non-Cash$2.0M
= Operating Cash Flow$6.9M
- Capex-$5.6M
= Free Cash Flow$1.2M

Analysis

FY2025 free cash flow is $1.2M. FCF conversion is -6.7% of net income. Operating cash flow was $6.9M, with capex of -$5.6M. The largest bridge item is D&A at $14.2M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 6, 2026
4Statement of changes in beneficial ownershipOct 30, 2026
10-QQuarterly reportOct 26, 2026
8-KCurrent reportOct 26, 2026
4Statement of changes in beneficial ownershipSep 30, 2026

Does MED generate free cash flow?

Medifast, Inc. (MED) generated $1.25M of free cash flow in fiscal 2025.

How much operating cash flow does MED produce?

Operating cash flow was $6.86M, before capital expenditures of $5.61M.